SCHEMBL21451306

SCHEMBL21451306

CC(C)(C)c1ccc2cc(C(F)(F)F)nnc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 1/20 0.41
▸ KIF11 P52732 1/20 0.38
▸ SCN10A Q9Y5Y9 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ LRRK2 Q5S007 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ SCN5A Q14524 1/20 0.32
▸ PDPK1 O15530 2/20 0.32
▸ TRPV1 Q8NER1 1/20 0.32
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ CCNE2 O96020 1/20 0.31
▸ CCNA2 P20248 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4548624 0.87 TSHR (0.37) KIF11SCN10AKCNH2LRRK2ALDH1A1
SCHEMBL21451305 0.84 BACE1 (0.37) BACE1KDM4E
SCHEMBL21849174 0.77 BACE1 (0.50) BACE1KIF11SCN10AKDM4EKCNH2
SCHEMBL14427134 0.73 TERT (0.46) KIF11SCN10AKDM4EKCNH2ALDH1A1
SCHEMBL5503119 0.72 KDM4E (0.46) BACE1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL25782693 0.69 SCN10A (0.37) KIF11SCN10AKCNH2LRRK2ALDH1A1
SCHEMBL13438759 0.69 SCN10A (0.37) KIF11SCN10AKCNH2LRRK2ALDH1A1
SCHEMBL30753423 0.69 KDM4E (0.49) BACE1KIF11SCN10AKDM4EKCNH2
SCHEMBL2707037 0.68 TSHR (0.39) KIF11SCN10AKCNH2ALDH1A1HPGD
SCHEMBL18210644 0.67 KIF11 (0.55) BACE1KIF11KDM4EKCNH2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10870630-B2 Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors MERCK SHARP & DOHME CORP. 2020-12-22 — — US disclosed
US-20190308945-A1 SUBSTITUTED BICYCLIC HETEROARYL ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2019-10-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10870630-B2 Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors CHRNA7, CHRNA5, CHRNA2 BACE1 133/4885KIF11 4265/4885SCN10A 833/4885
US-20190308945-A1 SUBSTITUTED BICYCLIC HETEROARYL ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS CHRNA7, CHRNA5, CHRNA2 BACE1 133/4885KIF11 4265/4885SCN10A 833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback